A novel contraceptive vaginal ring releasing etonogestrel 120 μg and ethinyl oestradiol 15
μg daily over a period of 3 weeks was tested. Each ring was used for one cycle, comprising …

OBJECTIVE: To assess the contraceptive efficacy, cycle control, tolerability, and user
acceptability of a novel combined contraceptive vaginal ring for up to 13 cycles. METHODS …

BACKGROUND: This trial was conducted to compare cycle control with vaginal ring a
combined contraceptive vaginal ring, and a combined oral contraceptive (COC) delivering …

OBJECTIVE: The purpose of this study was to compare cycle control and tolerability of the
NuvaRing (NV Organon, Oss, The Netherlands), a novel combined contraceptive vaginal …

This open-label, randomized, Phase III study compared the efficacy and tolerability of and
compliance with NuvaRing, a combined contraceptive vaginal ring releasing 15 μg of …

In a multicenter 1-year trial of contraceptive vaginal rings (rings) involving 150 women, three
dose combinations of the progestin Nestorone®(NES) and ethinylestradiol (EE) were …

Contraceptive vaginal rings (CVR) offer a new, effective contraceptive option, expanding the
available choices of hormonal contraception. Various ring prototypes have been evaluated …

Development efforts on contraceptive vaginal rings were initiated over 40 years ago based
on two principles: the capacity of the vaginal epithelium to absorb steroids and the capacity …

Objective To assess the pharmacokinetics of etonogestrel and ethinylestradiol released from
a novel combined contraceptive vaginal ring (NuvaRing®) releasing etonogestrel 120µg …

The contraceptive vaginal ring is a novel contraceptive method that offers unique
advantages. Intravaginal delivery of both estrogen and progesterone allows continuous …